No Data
Novo Nordisk's Weight-Loss Drug Retains Safety Profile Despite Concerns -- Market Talk
1204 GMT - Novo Nordisk's semaglutide--the active ingredient in its blockbuster weight-loss and diabetes treatments--belongs to one of the most derisked therapeutic drug classes in history from a safe
A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.
A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.
Can it cause blindness? Research shows that the weight loss drug Ozempic is related to a rare blindness condition, and weight loss drug concept stocks have fallen.
Hidden risk of rare blindness.
A Harvard study shows a link between weight loss drug Ozempic and rare vision loss, causing a nearly 5% drop in novo-nordisk a/s stocks.
Some doctors have pointed out that there is currently no evidence to prove a direct causal relationship between drug use and eye complications, as some cases only appear after several months of medication.
US stocks closing | S&P, Nasdaq hit new highs again! Tesla rose nearly 35% in seven days, and Nvidia rose more than 4.5% overnight.
S&P has reached a new high for two consecutive days, NASDAQ has reached a new high for three consecutive days, and Dow's intraday decline has significantly narrowed. Google, Apple, Microsoft, Taiwan Semiconductor in the US stock market have all reached new highs. Tesla has risen by 35% in seven days, and the chip stock index has risen by nearly 2%.
Research warns of new risks with "miracle weight-loss drugs": there may be a correlation with a certain eye disease.
① The study came from the Massachusetts Eye and Ear Hospital in the US, a hospital that specializes in treating eye, ear, nose, throat, and head and neck diseases, and is also a teaching hospital affiliated to Harvard Medical School; ② The results showed that taking simeglutide prescriptions poses a potential risk of developing NAION, but further research is needed to assess the causal relationship.